Lantheus Holdings logo

LNTH

Lantheus Holdings

$82.86

Earnings Summary

Revenue
$88.84Mn
Net Profits
$13.6Mn
Net Profit Margins
15.3%

Highlights

Revenue:

Lantheus Holdings’s revenue jumped 13.94% since last year same period to $88.84Mn in the Q2 2017. On a quarterly growth basis, Lantheus Holdings has generated 9.19% jump in its revenue since last 3-months.

Net Profits:

Lantheus Holdings’s net profit jumped 84.97% since last year same period to $13.6Mn in the Q2 2017. On a quarterly growth basis, Lantheus Holdings has generated 228.54% jump in its net profits since last 3-months.

Net Profit Margins:

Lantheus Holdings’s net profit margin jumped 62.33% since last year same period to 15.3% in the Q2 2017. On a quarterly growth basis, Lantheus Holdings has generated 200.88% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Lantheus Holdings post its latest quarter earnings

EPS Estimate Current Quarter
0.96
EPS Estimate Current Year
0.96

Highlights

EPS Estimate Current Quarter:

Lantheus Holdings’s earning per share (EPS) estimates for the current quarter stand at 0.96 - a 15.66% jump from last quarter’s estimates.

EPS Estimate Current Year:

Lantheus Holdings’s earning per share (EPS) estimates for the current year stand at 0.96.

Key Ratios

Key ratios of the Lantheus Holdings post its Q4 2022 earnings

Return on Assets (ROA)
0.02
Return on Equity (ROE)
0.06

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Lantheus Holdings’s return on assets (ROA) stands at 0.02.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Lantheus Holdings’s return on equity (ROE) stands at 0.06.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2018-05-02
0.22
0.22
0%
2019-02-20
0.14
0.24
71.43%
2018-08-01
0.22
0.26
18.18%
2018-10-30
0.18
0.24
33.33%

Company Information

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow™ serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New York, New Jersey, Canada and Sweden.

Organisation
Lantheus Holdings
Headquarters
331 Treble Cove Road, North Billerica, MA, United States, 01862
Employees
698
Industry
Health Technology
CEO
Mary Heino

Trading and brokerage services provided by

Alpaca iconDrivewealth icon

Banking and Remittance services provided by

SBM icon

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*